Increasing Awareness of the Human Papillomavirus (HPV) Vaccine for Women 18–45 Years of Age
The human papillomavirus (HPV) vaccine prevents cancer and is highly effective; however, the uptake has been low in the United States of America (USA) and among the most vulnerable populations. A recent Center for Disease Control (CDC) report highlighted that approximately 13,000 new cases of cervic...
Main Authors: | Alina Cernasev, Alexandria Grace Yoby, Tracy Hagemann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Women |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-4184/3/3/27 |
Similar Items
-
Regular Healthcare Provider Status Does Not Moderate Racial/Ethnic Differences in Human Papillomavirus (HPV) and HPV Vaccine Knowledge
by: Trisha L. Amboree, et al.
Published: (2021-07-01) -
Racial and ethnic disparities in human papillomavirus (HPV) vaccine uptake among United States adults, aged 27–45 years
by: Natalie L. Rincon, et al.
Published: (2024-12-01) -
Sociodemographic factors associated with HPV awareness/knowledge and cervical cancer screening behaviors among caregivers in the U.S
by: Jiyeong Kim, et al.
Published: (2022-08-01) -
Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13–17 by metropolitan statistical area (MSA) status, National Immunization Survey – Teen, 2013 – 2017
by: Tanja Y. Walker, et al.
Published: (2020-03-01) -
Barriers and Facilitators of Romanian HPV (Human Papillomavirus) Vaccination
by: Loredana Sabina Cornelia Manolescu, et al.
Published: (2022-10-01)